CEO Executive AssistantWound Care Program Coordination Is a Strategic Priority for Healthcare CEOs
Wound care program coordination sits at the intersection of clinical quality, outpatient volume growth, and population health strategy for healthcare CEOs. Chronic wound management, diabetic limb salvage, and hyperbaric oxygen therapy (HBOT) represent a growing clinical and financial opportunity for health systems and hospital networks. At the same time, these programs carry meaningful regulatory complexity: CMS quality reporting requirements, outpatient billing compliance, and the operational demands of managing wound care centers as distinct service lines alongside the rest of a complex health system.
For healthcare CEOs, the challenge is not understanding why wound care matters. It is maintaining consistent executive engagement across the program’s full governance and operational landscape while managing the broader demands of health system leadership. That is precisely where executive assistant support creates value that compounds over time.
The EA who understands wound care program coordination, from CMS reporting cycles to hyperbaric medicine ROI analysis to podiatry and vascular surgery partner relationships, builds the administrative infrastructure that allows the CEO to lead this program with the attention it deserves. This article explains what that infrastructure looks like in practice.
Scheduling Wound Care Center Leadership Reviews
Wound care centers operate as distinct service lines within larger health systems, often under a management services organization (MSO) model with a contracted clinical management company providing the operational framework. For CEOs, the governance relationship with wound care center leadership is distinct from the relationship with, say, a cardiovascular service line: there is often a contracted management partner involved, the center operates in an outpatient setting with its own volume and financial dynamics, and the clinical staff includes specialists from multiple disciplines who may or may not be employed by the health system.
The EA establishes a structured leadership review cadence for the CEO’s engagement with wound care center program leadership. A quarterly executive review is the foundation: a 90-minute session that includes the CEO, the CMO or chief of surgery, the wound care program director, the MSO partner’s regional director if applicable, and the CFO or service line finance lead. This meeting covers program performance across the key metrics: patient volume, healing rate outcomes, CMS quality reporting status, and financial performance against budget.
The EA owns the scheduling and pre-read logistics for these quarterly reviews. They establish when materials are due from each contributor, ensure that the format is consistent across quarters so the CEO builds cumulative familiarity with the data, and prepare a discussion agenda that focuses on strategic decisions rather than recapping reports the CEO should have read in advance. The CEO’s time in these sessions is spent leading the conversation, not parsing spreadsheets.
In addition to the quarterly review, the EA coordinates a monthly touchpoint between the CEO and the wound care program director: a 30-minute call or in-person meeting that covers emerging operational issues, near-term decisions, and any regulatory or partner developments that warrant early executive awareness. These monthly touchpoints are the early warning system that prevents small issues from growing into board-level surprises.
Coordinating CMS Wound Care Quality Reporting Briefings
CMS quality reporting for outpatient wound care programs is driven primarily by the Outpatient Quality Reporting (OQR) program, which establishes measures that wound care centers must submit to receive full Medicare payment updates. The measures cover wound healing outcomes, limb salvage rates, infection rates, and patient experience data. Wound care centers that fail to report accurately and on time face payment reductions that directly affect the program’s financial performance.
For healthcare CEOs, CMS reporting compliance for wound care is a governance accountability, not an operational detail. If a wound care center’s reporting is inaccurate, incomplete, or late, the financial and reputational consequences fall at the health system level. The CEO needs to know that the reporting infrastructure is sound and that any emerging compliance issues reach executive awareness before they become enforcement matters.
The EA coordinates the CEO’s briefings on CMS wound care quality reporting by maintaining a regulatory reporting calendar and ensuring that a compliance briefing reaches the CEO at least quarterly. This briefing, prepared by the quality and compliance team, covers the status of all active OQR measures, any data quality issues identified in the current reporting cycle, the wound care center’s performance trajectory on key quality metrics, and any recent CMS guidance that affects the reporting requirements or measure specifications.
When CMS releases new guidance on wound care quality measurement or outpatient prospective payment system updates that affect wound center reimbursement, the EA ensures the CEO receives a synthesized briefing within five business days. Not a forwarded document, but a two-page summary: what changed, what it means for the program’s financial model, what decisions it triggers, and the recommended response from the clinical and finance teams. The CEO reads implications and makes decisions, not regulatory text.
The EA also tracks the wound care program’s performance on any value-based care contracts that include wound management as a covered population. For health systems with ACO agreements or bundled payment arrangements that encompass diabetic patients, wound care outcomes data is relevant not just to the wound care center but to the CEO’s overall value-based care performance accountability.
Value-based care coordination provides a broader framework for managing the administrative dimensions of value-based care contracting and performance oversight, including the reporting cycles that connect wound care outcomes to population health accountability.
Tracking Outpatient Wound Center Volume and Healing Rate Reporting Cycles
The operational metrics that matter most for wound care program performance are patient volume, healing rates, and limb salvage outcomes. These three metrics drive both the clinical quality narrative and the financial performance of the program. Volume determines revenue. Healing rates determine quality standing and CMS compliance. Limb salvage outcomes, particularly for diabetic patients, are the most powerful evidence of the program’s clinical value and its contribution to the health system’s mission.
The EA works with the wound care program director and the data analytics team to establish a standardized monthly metrics dashboard for the CEO. This dashboard shows current month and year-to-date performance on the three core metrics, trend lines against the prior year, comparison to the program’s annual targets, and any metric flags that warrant explanation or executive attention. The dashboard is delivered to the CEO on a fixed date each month and reviewed in the CEO’s monthly touchpoint with the program director.
The monthly dashboard serves a second purpose: it is the source document for the quarterly executive review and for board-level reporting. When the CEO presents on wound care program performance to the board or to the health system’s quality committee, they are working from data they have reviewed every month. There are no surprises in the presentation because there were no surprises in the data.
The EA also tracks the wound care program’s performance against any public commitments the health system has made on wound care outcomes: published quality reports, community health needs assessment response commitments, or value-based care contractor performance guarantees. If the program’s trend line puts any of those commitments at risk, the EA ensures the CEO is aware with enough lead time to make decisions about operational intervention before the commitment is missed.
Managing Podiatry and Vascular Surgery Partner Meetings
Wound care programs serve a patient population that requires multidisciplinary clinical management. Diabetic foot wounds, venous leg ulcers, and arterial insufficiency wounds frequently require coordination between wound care specialists, podiatric surgeons, vascular surgeons, infectious disease specialists, and primary care providers. For health systems where some of those specialists are employed and others are in independent practice or group practices with affiliation arrangements, managing those clinical relationships is both a care coordination imperative and a partnership management challenge.
The CEO’s role in managing podiatry and vascular surgery partner relationships is primarily strategic: setting the tone for partnership, addressing any systemic issues that affect the relationship, and ensuring that the health system’s commitment to the wound care program is visible and credible to independent clinical partners who have other options. That strategic engagement happens in a small number of well-prepared meetings each year, not in the daily operational dialogue that program directors handle.
The EA maintains a partner relationship calendar for podiatry and vascular surgery partners that maps the CEO’s direct engagement touchpoints across the year. For employed specialists, this typically means inclusion in the quarterly wound care program executive review. For independent practice partners, it means a separate semi-annual relationship meeting and any event-driven engagement when a partnership issue requires CEO-level attention.
When a podiatry or vascular surgery practice is considering expanding its referral relationship with the wound care center, or when a partnership issue has escalated to the point where the CEO’s direct engagement is needed, the EA prepares a briefing that gives the CEO full context: the nature of the relationship, the current state of clinical collaboration, the specific question or issue at hand, and the recommended positioning for the meeting. The CEO does not walk into a partner meeting without that preparation.
The EA also coordinates the CEO’s participation in clinical quality forums where wound care outcomes are reviewed alongside the outcomes of podiatric and vascular surgical interventions. These forums are where the integrated care model is held accountable, and CEO presence sends a clear message about health system leadership’s commitment to the wound care program’s clinical mission.
Surgical services coordination provides a complementary framework for managing the administrative dimensions of surgical specialty partnerships, including the scheduling and briefing architecture that supports productive CEO engagement with surgical service line leaders.
Preparing Board Presentations on Wound Care Performance and Hyperbaric Medicine ROI
The board’s oversight of the wound care program is driven by a set of concerns that are familiar from any outpatient service line review: financial performance against budget, quality outcomes relative to benchmarks and accreditation standards, strategic fit with the health system’s overall portfolio, and capital investment decisions. Hyperbaric oxygen therapy adds a distinct dimension: it is a relatively capital-intensive intervention with strong clinical evidence for specific indications, a Medicare reimbursement profile that requires close compliance oversight, and an ROI story that boards often need help evaluating in full context.
The EA manages the board prep cycle for wound care program presentations with a structured timeline that begins three weeks before each board or quality committee meeting where wound care is on the agenda. They identify which sections of the presentation require contributions from clinical, finance, and operations, establish submission deadlines, schedule the CEO’s review session, and manage the revision process through to the final board-ready document.
A well-structured wound care board presentation covers four areas. First, clinical performance: healing rates, limb salvage outcomes, patient satisfaction scores, and comparison to national wound care benchmarks or accreditation standards. Second, financial performance: program revenue, cost structure, and operating margin against budget, with volume and payer mix analysis. Third, hyperbaric medicine ROI: the capital invested in hyperbaric chambers, the utilization rate, the revenue generated per treatment session, the compliance posture on CMS’s hyperbaric billing guidelines, and the net contribution of the HBOT program to the wound care center’s financial model. Fourth, strategic direction: any program expansion plans, equipment or facility investment decisions, or partnership changes requiring board awareness or approval.
The EA prepares the CEO’s talking points for the board session, with specific attention to the questions boards most commonly raise about hyperbaric medicine: Medicare audit risk on HBOT billing, the evidence base for HBOT in specific indications, and the capital replacement timeline for aging hyperbaric chambers. These questions are predictable. Being prepared for them is the EA’s responsibility.
According to McKinsey’s analysis of value-based care transformation in health systems, health systems that build strong specialty program performance in high-complexity chronic disease management, including diabetic wound care and limb salvage, position themselves effectively for both fee-for-service and value-based contracting environments. The wound care program is not just a service line. It is a strategic asset for the health system CEO.
Wound Care Program Coordination as Executive Accountability
Healthcare CEOs who lead wound care programs that deliver genuine clinical and financial performance share a consistent operating characteristic: they are engaged with the program at the right level of regularity and depth. They know the healing rates. They understand the HBOT billing compliance posture. They have direct relationships with the podiatry and vascular surgery partners who are essential to the program’s clinical model. And they present to their boards with the confidence that comes from consistent engagement with the data.
The EA who builds the administrative infrastructure behind that engagement, the scheduling architecture, the CMS reporting calendar, the partner relationship management, the board prep cycle, is not performing background support. They are creating the conditions for the CEO to lead a clinically and financially important program with the discipline and consistency that transforms a wound care center from a contract obligation into a genuine health system differentiator.